Hernández BF, López CJM, Rodríguez MJR, Peralta PML, Rodríguez GRS, Ortiz AAR

Language: Spanish
References: 21
Page: 325-331
PDF size: 257.88 Kb.

ABSTRACT

Objectives: To estimate the frequency of asymptomatic bacteriuria in pregnant women attended in Family Medicine Units of the Instituto Mexicano del Seguro Social and to determine the in vitro sensitivity rate of the microorganisms to ampicillin, trimethoprim-sulfamethoxazole, nitrofurantoin and amikacin.
Patients and methods: We carried out an observational, prospective and transversal study at Family Medicine Units 62 and 64 of the Mexico State Delegation, located in the urban area of Mexico City. Women with lesser than 32 weeks of pregnancy without urinary tract symptoms were included. Urine culture of a midstream urine specimen with ≥ 10⁵ colony forming units/mL urine of an only germen was used as the gold standard. The in vitro antimicrobial sensitivity was established according to the Bauer Kirby technique.
Results: 874 pregnant women were included and 73 had a positive urine culture, with a frequency of 8.4%, IC_95% = 6.6 - 10.2%, of asymptomatic bacteriuria. Escherichia coli was the most frequent isolated agent (77%). In vitro sensitivity to ampicillin of the microorganisms isolated was of 27%, IC_95% = 16 - 38%; to trimethoprim-sulfamethoxazole of 40%, IC_95% = 29 - 51%; to amikacin of 68%, IC_95% = 57 - 79%, and to nitrofurantoin of 79%, IC_95% = 70 - 88%.
Conclusions: The frequency of asymptomatic bacteriuria in the studied population is similar to the reported by the literature. The in vitro sensitivity rates of E. coli to ampicillin and to trimethoprim-sulfamethoxazole are very low. The best sensitivity corresponded to the nitrofurantoin. The treatment of the asymptomatic bacteriuria must be based on the local patterns of antimicrobial sensitivity and resistance.

REFERENCES

1. Delzell JE, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713-21.

2. Schieve LA, Handler A, Hershow R, Persky V, Davis F. Urinary tract infection during pregnancy: Its association with maternal morbidity al perinatal outcome. Am J Public Health 1994;84:405-10.

3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and economic cost. Am J Med 2002;113(1A):5S-13S.

4. Trejo y Pérez JA, Leyva-Hernández B, Ducoing-Díaz DLR, Vázquez-Estrada L, Tomé-Sandoval P. Guía clínica para la atención prenatal. Guías de práctica clínica para medicina familiar. Instituto Mexicano del Seguro Social, 2003:1-12.

5. Patterson TF, Andriole VT. Bacteriuria in pregnancy. Current treatment options in infectious diseases 2003;5:81-87.

6. Antimicrobial therapy for obstetric patients. ACOG educational bulletin No. 245. Washington, D.C.: American College of Obstetricians and Gynecologists, March 1998;245:8-10.

7. U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria: Recommendation Statement. Am Fam Physician 2005;71(8);1575-6.

8. Vázquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev 2003;1:update software.

9. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2000;2:CD000490.

10. Villar J, Lyndon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev 2000;49:CD000491.

11. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-adquired urinary tract infections. Ann Intern Med 2001;135(1):41-50.

12. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281(8):736-38.

13. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS project. J Antimicrob Chemother 2003;51:69-76.

14. Rivas-Espinoza V, Ortiz MA. Resistencia antimicrobiana de Escherichia coli uropatógena aislada de pacientes comunitarios. Revista Mexicana de Patología Clínica 1998;45(4):201-05.

15. López-Carmona JM, Salazar-López MA, Rodríguez-Moctezuma JR, López-Delgado ME, Manrique-Lizárraga JM. Comparación de tres esquemas antimicrobianos para cistitis aguda en mujeres con diabetes mellitus tipo 2. Rev Med IMSS 2007. En prensa.

16. Guía diagnóstico-terapéutica para la atención prenatal en medicina familiar. Dirección de Prestaciones Médicas. Instituto Mexicano del Seguro Social, 2004.

17. Lineamiento técnico-médico para la vigilancia del embarazo, del puerperio y sus complicaciones, en medicina familiar. Dirección de Prestaciones Médicas. Instituto Mexicano del Seguro Social, 2005.

18. National Committee for Clinical Laboratory Standards. Performance standars for antimicrobial susceptibility testing. Wayne, PA:NCCLS,1998.

19. Huovinen P, Sundström L, Swedberg G, Sköld O. Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 1995;39(2):279-89.

20. Warren JW, Abrutyn E, Heberl JR, Johnson JR, Schaeffer AH, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-58.

21. González Pedraza-Avilés A, Medina-Zarco L, Moreno-Castillo Y, Ortiz-Zaragoza C, Dávila-Mendoza R. Prevalencia de bacteriuria asintomática en adultos mayores, y sensibilidad in vitro a antimicrobianos. Arch Med Fam 2004;6(2):52-56.